Provided by Tiger Fintech (Singapore) Pte. Ltd.

C4 Therapeutics, Inc.

2.12
+0.07003.41%
Post-market: 2.150.0300+1.42%19:36 EDT
Volume:750.70K
Turnover:1.59M
Market Cap:150.54M
PE:-1.44
High:2.19
Open:2.03
Low:1.99
Close:2.05
Loading ...

C4 Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview

Reuters
·
28 Jul

Top Penny Stocks To Watch In July 2025

Simply Wall St.
·
10 Jul

Malaysia’s East Coast Rail Link: Project at risk of delay from cable, equipment theft

CNA
·
23 Jun

C4 Therapeutics Holds Annual Stockholders Meeting

TIPRANKS
·
19 Jun

C4 Therapeutics Inc. Conducted Annual Stockholders Meeting

Reuters
·
19 Jun

CCCG Boosts Stake in CCCC to Strengthen Market Confidence

TIPRANKS
·
09 Jun

C4 Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
07 May

C4 Therapeutics Q1 2025 EPS $(0.37) Beats $(0.47) Estimate, Sales $7.24M Beat $4.45M Estimate

Benzinga
·
07 May

BRIEF-C4 Therapeutics Q1 EPS USD -0.37

Reuters
·
07 May

Changi Airport Terminal 5 contracts worth S$4.75 billion awarded

businesstimes
·
06 May

C4 Therapeutics Inc expected to post a loss of 45 cents a share - Earnings Preview

Reuters
·
02 May

CCCC Releases 2025 Q1 Unaudited Financial Report

TIPRANKS
·
27 Apr

April 2025's Standout Penny Stocks

Simply Wall St.
·
23 Apr

CCCC Design & Consulting Group 2024 Profit Down 0.8%, Revenue Slips 8%

MT Newswires Live
·
28 Mar

C4 Therapeutics (CCCC) Loses -21.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks
·
03 Mar

UBS Adjusts C4 Therapeutics Price Target to $3.50 From $4, Maintains Neutral Rating

MT Newswires Live
·
03 Mar

C4 Therapeutics: Promising Clinical Developments and Strategic Plans Justify Buy Rating

TIPRANKS
·
02 Mar

C4 Therapeutics Reports Strong 2024 Financial Performance and Clinical Progress

TIPRANKS
·
28 Feb

C4 Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Feb

C4 Therapeutics, Inc. (CCCC) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
27 Feb